Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer

A higher risk of death from coronavirus disease 19 has been shown for patients with solid cancers or haematological malignancies (HM). Thanks to the accelerated development of anti–SARS-SoV-2 vaccines in less than a year since the start of the global pandemic, patients with cancer were quickly prior...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrière, Jérôme, Re, Daniel, Peyrade, Frédéric, Carles, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Current Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260097/
https://www.ncbi.nlm.nih.gov/pubmed/34243079
http://dx.doi.org/10.1016/j.ejca.2021.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260097/
https://www.ncbi.nlm.nih.gov/pubmed/34243079
http://dx.doi.org/10.1016/j.ejca.2021.06.008

Ejemplares similares